CSL Behring Closes California R&D Site, Shifts Operations to Massachusetts Amid Strategic Repositioning

Closure and Relocation:
CSL Behring is closing its Pasadena, California R&D site and relocating operations to Waltham, Massachusetts15.

Reason for Closure:
The closure is part of a larger strategic repositioning of the company’s gene therapy and ex vivo work15.

Impact on Employees:
Approximately 30 employees will be affected by the closure1.

Broader Context:
This move reflects a broader trend in the biotech industry, where companies are reassessing and adjusting their research and development strategies4.

Industry Trends:
The cell and gene therapy sector has seen significant changes, including downsizing efforts and strategic pivots by various companies45.

Sources:

1. https://endpts.com/csl-behring-will-close-california-office-as-part-of-shrinking-ex-vivo-work/

4. https://www.fiercebiotech.com/biotech/genentech-shut-down-cancer-immunology-department-amid-broader-downsizing-efforts

5. https://www.fiercebiotech.com/biotech/csl-behring-shuts-down-california-cell-and-gene-therapy-rd-site-amid-group-pivot